Vertex Pharmaceuticals Inc. Stock Sheds 4.3%, Underperforms Peers
Dow Jones2026/10/13 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. slid 4.3% to $485.22 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index remaining mostly unchanged at 7,805.45 and the Dow Jones Industrial Average falling 0.3% to 51,670.10.
This was the stock's second consecutive day of losses.
Vertex Pharmaceuticals Inc. closed 13.4% below its 52-week high of $560.25, which the company achieved on September 3rd.
The stock demonstrated a mixed performance when compared to some of its peers, as AbbVie Inc. fell 2.4% to $274.36, Krystal Biotech Inc. fell 3.3% to $321.16, and Arcturus Therapeutics Holdings Inc. fell 4.60% to $12.03.
Trading volume totaled 1.1 million, compared to the 50-day average of 1.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 13, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
MSCI Asia Pacific Index drops 4.8%
SoftBank initiates equity sale of approximately $200 million in India’s Lenskart
Lyft (LYFT.US) plans to significantly expand its Waymo autonomous taxi fleet in Nashville by the end of the year
Lyft plans to expand its fleet of Waymo driverless taxis in Nashville by the end of the year.
Japanese stocks fall below 57,000 points
Crypto prices
More
